A pharmaceutical composition comprising extract or fraction of Gardeniae Fructus for preventing or treating osteoporosis
KR20160088840A
Composition for prevention or treatment of glutamate toxicity related diseases containing butyrolatone derivatives or pharmaceutically acceptable salts thereof as an active ingredient
KR20160064053A
Composition for Cancer Diagnosis and Therapy Using Leucine Zipper Pair
KR20160087368A
Behcet's disease human cell model and use thereof
KR20160041892A
Method for Culturing Microalge Thraustochytrid Using Palm Empty Fruit Bunch Hydrolysate and Method for Preparing Biooil Through the Same
KR20160040478A
Surface plasmon resonance sensor system capable of real-time monitoring of the sample and analysis method using the same
KR20160025549A
Composition of anti―metabolic syndrome effects containing extract of unripened Rubus coreanus Miquel
WO2016122234A1
Composition for drinking water agent and feed having companion animal urine odor removal function, comprising mixture of herbal extracts as effective ingredient
KR20160085717A
Kit for detecting virus
KR20160006649A
AGR2 homo-dimer attenuating ER stress induced cell death
KR20160003590A
Composition for inhibiting motility or increasing sensitivity against antibiotics containing volatile organic compound from Bacillus subtilis as effective component and uses thereof
KR20160107091A
High throughput photobioreactor
KR20160060586A
Pharmaceutical composition comprising ursolic acid acetate for preventing or treating STAT3 mediated disease and use thereof
KR20150133678A
Neuroprotective composition comprising extract or fractions of Schinus terebinthifolius Raddi as a active ingredient
KR101611212B1
Microorganism Inhibiting Methane Producing Microorganism and Use therof
KR20160054426A
TodS mutein comprising PAS1 mutein and use thereof
KR20160052328A
Protein Expression System Induced by Heavy Metals And Biosensor for Detecting Heavy Metals
WO2016068543A1
System for protein expression induced by heavy metals, and biosensor for detecting heavy metals
KR20150123213A
Pharmaceutical composition for the treatment of colorectal cancers or inhibition of metastasis containing the expression or activity inhibitors of cadherin―11
WO2016048048A1
Method for preparing ε-caprolactam by using novel caprolactam converting enzyme
